Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5P7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,820
Award facts
- Contract value 100% obligated
- $50,820.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,820.29 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order execution under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill open competition procurement requirements across diverse therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices. As the child entity of Cencora, Inc., AmerisourceBergen leverages its parent's substantial IDC with DLA to efficiently supply essential pharmaceutical products required by military treatment facilities and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FJ5P7?
SPE2DR26FJ5P7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FJ5P7 worth?
The government has obligated $50,820 on SPE2DR26FJ5P7.
Is contract SPE2DR26FJ5P7 an order under another contract?
Yes. SPE2DR26FJ5P7 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5P7 competed?
The extent of competition for SPE2DR26FJ5P7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award